KN035 for dMMR/MSI-H Advanced Solid Tumors

计划入组 200 人 · 首次发布于 2018 年 9 月 12 日

Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors

计划入组 17 人 · 首次发布于 2019 年 2 月 6 日

QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors

计划入组 86 人 · 首次发布于 2020 年 3 月 30 日

WRN Inhibitors program (MSI-high tumors)

Werner inhibitor (MSI-high cancers/sensitive cancers)

MSI-733

MSI ASIA PACIFIC

Australia

MSI Methylation Sciences Inc

Canada

HIGH POINT UNIVERSITY

United States

IDEAYA Biosciences' Werner Helicase Inhibitor IDE275 Cleared for Phase 1 Trial in MSI-High Solid Tumors

Novartis' Oral WRN Helicase Inhibitor HRO761 Targets MSI-High and dMMR Tumors

Vividion Secures Exclusive Rights to First-in-Class WRN Inhibitor VVD-214 for MSI-High Cancers